Medpage Today on MSN6d
SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis ProgressionFor the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...
Medpage Today on MSN6d
Study Questions Need to Hold SGLT2 Inhibitors Before SurgeryPreoperative use of SGLT2 inhibitors among patients with type 2 diabetes undergoing emergency surgery was not associated with ...
Medpage Today on MSN17h
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression RiskAmong 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD ...
A recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause chronic kidney disease by impairing kidney function. Chronic ...
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback